LAUREN SMITH: Open Payments
NPI 1427675800 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,469 in 56 payments from 26 companies in 2025. Trend: 2023 $1,504 · 2024 $2,020 · 2025 $1,469
Food & beverage: $1,269Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $143 |
| Daiichi Sankyo Inc. | 3 | $139 |
| Merck Sharp & Dohme LLC | 5 | $137 |
| Novartis Pharmaceuticals Corporation | 6 | $130 |
| Gilead Sciences, Inc. | 1 | $97 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| GENZYME CORPORATION | 3 | $74 |
| Regeneron Healthcare Solutions, Inc. | 2 | $68 |
| BeOne Medicines USA, Inc. | 2 | $56 |
| Stemline Therapeutics Inc. | 3 | $55 |
Products named: Enhertu, RYBREVANT, KEYTRUDA, Trodelvy, LIBTAYO, PLUVICTO, TEVIMBRA, Nubeqa.
Industry payments across MO — which companies pay providers there.
